283 related articles for article (PubMed ID: 2859981)
1. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs.
Kemali D; Maj M; Ariano MG; Salvati A
Encephale; 1985; 11(1):31-4. PubMed ID: 2859981
[TBL] [Abstract][Full Text] [Related]
2. Effects of neuroleptics on platelet monoamine oxidase activity.
Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C
Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230
[TBL] [Abstract][Full Text] [Related]
3. Platelet monoamine oxidase activity in schizophrenia: relationship to family history of the illness and neuroleptic treatment.
Maj M; Ariano MG; Pirozzi R; Salvati A; Kemali D
J Psychiatr Res; 1984; 18(2):131-7. PubMed ID: 6747911
[TBL] [Abstract][Full Text] [Related]
4. Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity.
Sullivan JL; Coffey CE; Basuk B; Cavenar JO; Maltbie AA; Zung WW
Biol Psychiatry; 1980 Feb; 15(1):113-20. PubMed ID: 7357050
[TBL] [Abstract][Full Text] [Related]
5. Low platelet MAO activity in chronic schizophrenics: a long-term effect of neuroleptic treatment?
Del Vecchio M; Maj M; D'Ambrosio A; Kemali D
Psychopharmacology (Berl); 1983; 79(2-3):177-9. PubMed ID: 6133302
[TBL] [Abstract][Full Text] [Related]
6. Platelet monoamine oxidase in schizophrenia: a meta-analysis.
Marcolin MA; Davis JM
Schizophr Res; 1992 Sep; 7(3):249-67. PubMed ID: 1356426
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia.
Baron M; Gruen R; Levitt M; Kane J
Psychiatry Res; 1982 Oct; 7(2):179-87. PubMed ID: 6128754
[TBL] [Abstract][Full Text] [Related]
8. Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients.
Meltzer HY; Duncavage MB; Jackman H; Arora RC; Tricou BJ; Young M
Am J Psychiatry; 1982 Oct; 139(10):1242-8. PubMed ID: 6127035
[TBL] [Abstract][Full Text] [Related]
9. Platelet monoamine oxidase response to lithium treatment in psychiatric patients.
Huang LG; Bowden CL
J Clin Psychopharmacol; 1984 Dec; 4(6):326-31. PubMed ID: 6512000
[TBL] [Abstract][Full Text] [Related]
10. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
[TBL] [Abstract][Full Text] [Related]
11. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
[TBL] [Abstract][Full Text] [Related]
12. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM
Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
[TBL] [Abstract][Full Text] [Related]
13. [Multiple forms of thrombocyte monoamine oxidase in patients with manic-depressive psychosis and recurrent schizophrenia].
Smirnov AV; Prilipko LL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(4):76-8. PubMed ID: 3414255
[TBL] [Abstract][Full Text] [Related]
14. Schizophrenic outcome in late life: symptom state and platelet monoamine oxidase activity.
Bridge TP; Jeste DV; Wise CD; Potkin SG; Phelps BH; Wyatt RJ
Psychiatry Res; 1984 Feb; 11(2):91-7. PubMed ID: 6143337
[TBL] [Abstract][Full Text] [Related]
15. A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients.
DeLisi LE; Wise CD; Bridge TP; Rosenblatt JE; Wagner RL; Morihisa J; Karson C; Potkin SG; Wyatt RJ
Psychiatry Res; 1981 Feb; 4(1):95-107. PubMed ID: 6111821
[TBL] [Abstract][Full Text] [Related]
16. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
[TBL] [Abstract][Full Text] [Related]
17. Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome.
Mann J; Thomas KM
Br J Psychiatry; 1979 Apr; 134():366-71. PubMed ID: 36192
[TBL] [Abstract][Full Text] [Related]
18. Human platelet MAO in drug-free and medicated schizophrenic patients.
Friedhoff AJ; Miller JC; Weisenfreund J
Am J Psychiatry; 1978 Aug; 135(8):952-5. PubMed ID: 27104
[TBL] [Abstract][Full Text] [Related]
19. Platelet monoamine oxidase activity: relation to genetic load of schizophrenia.
Baron M; Levitt M
Psychiatry Res; 1980 Sep; 3(1):69-74. PubMed ID: 6934558
[TBL] [Abstract][Full Text] [Related]
20. Platelet monoamine oxidase values and genetic heterogeneity in schizophrenia research.
Baron M; Levitt M; Perlman R
JAMA; 1981 Sep; 246(13):1418-21. PubMed ID: 7265444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
